SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC

Clinical trial NCT03004183 · COMPLETED

Trial details

NCT number: NCT03004183
Sponsor: The Methodist Hospital Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer Metastatic Triple-negative Breast Cancer

Start date: 2017-07-01
Primary completion: 2022-07-22
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.